ALK-Abello AS - Company Profile
Powered by 
All the data and insights you need on ALK-Abello AS in one report.
$295
- Save hours of research time and resources with
our up-to-date ALK-Abello AS Strategy Report
- Understand ALK-Abello AS position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
ALK-Abello AS Clinical Trials
Determine ALK-Abello AS go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of ALK-Abello AS Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| Vestibular Versus Sublingual Route of AIT Tablets | GDCT0439336 | short ragweed pollen (Ambrosia artemisiifolia) allergen extract ODT; standardized grass pollen [timothy (Phleum pratense)] allergen extract; standardized mite (Dermatophagoides pteronyssinus + Dermatophagoides farinae) allergen extract; standardized tree pollen [white birch (Betula verrucosa)] allergen extract ODT | Immunology; Ophthalmology; Respiratory | Allergic Rhinitis; Asthma; Birch Pollen Allergy; Conjunctivitis; Grass Pollen Allergy; House Dust Mite Allergy; Hypersensitivity; Perennial Allergic Rhinitis; Ragweed Pollen Allergy | Phase IV | Completed | Specialized Clinic in Allergies of the Capital |
| A Non-interventional Observational Study Assessing the Safety and Tolerability of Acarizax in Adults (18-65 Years of Age) | GDCT0437167 | standardized mite (Dermatophagoides pteronyssinus + Dermatophagoides farinae) allergen extract | Ophthalmology; Respiratory | Allergic Conjunctivitis; Allergic Rhinitis | Phase III | Withdrawn | ALK-Abello AS |
| Effect of Low Dose Intralymphatic Immunotherapy | GDCT0424262 | standardized grass pollen [timothy (Phleum pratense)] allergen extract | Ophthalmology; Respiratory | Allergic Rhinitis; Rhino-Conjunctivitis | Phase II/III | Completed | Aarhus University |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer